Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ (Hsp40) homolog, subfamily C, member 8 pseudogene is a non-functional genetic element in the human genome. Pseudogenes like this are remnants of formerly functional genes that have acquired mutations (such as frameshifts or premature stop codons) and lost their ability to code for functional protein products[2][4]. They may retain sequence similarity to their parent genes—in this case, the DnaJ (Hsp40) family of molecular chaperones, which are involved in protein folding and cellular stress response—but cannot perform the molecular functions of those genes. Pseudogenes generally do not produce protein or have a direct biological function, and they are not considered therapeutic targets[2][4]. No interacting drugs, biomarkers, or known safety concerns are associated with this pseudogene. Pseudogenes are recognized as gene copies with coding sequence deficiencies that prevent them from producing functional protein[2][4]. While some DnaJ (Hsp40) family proteins are involved in important cellular functions (such as cell stress response and cancer stem cell maintenance[5]), this specific entry (ENSG00000271702) is a pseudogene and not one of the functional family members, such as DNAJB8[5]. Information found refers to the existence and classification of the pseudogene, but it does not act as a receptor, enzyme, or protein with activity in health or disease[2][4][1]. This entry is a pseudogene and not a valid molecular target for therapy, drug design, or functional biology studies, conforming to recognized definitions and classifications of pseudogenes in genomics[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ (Hsp40) homolog, subfamily C, member 8 pseudogene.